Protocol Ledger

NCT07111468 · Phase III · COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis

Interventional Phase III clinical trial protocol NCT07111468 sponsored by Yuhan in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-08-19 Enrollment: 286 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT07111468
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)286 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07111468
Protocol FieldVerified Registry Value
NCT IdentifierNCT07111468
Consolidated Lead SponsorYuhan
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment286 participants (ACTUAL)
Registered Start Date2025-08-19
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07111468
Hospital Research SiteLocationSite Profile
Kangbuk Samsung HospitalSeoul, South KoreaOpen Hospital Dossier ->
Konkuk University Medical CenterSeoul, South KoreaOpen Hospital Dossier ->
Korea University Guro HospitalSeoul, South KoreaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI